Breakfast at AES Annual Meeting:

The breakfast meeting will be hosted by Key Opinion Leaders and Marinus Pharmaceuticals' management team who will provide additional information on the Company's recently completed Phase II trial of ganaxolone in RSE. KOLs will also present overviews of individual RSE patients treated during the trial.